EUCTR2005-003652-35-GB进行中（未招募）1 期
A randomised, double blind, placebo controlled study to assess the effect of testosterone treatment on arterial stiffness in patients with type 2 diabetes, peripheral vascular disease and hypogonadism. - Testosterone Replacement in Diabetes and Vascular Disease
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Male
入选标准
- •Male patients greater than 18 years of age.
- •Type 2 diabetes mellitus
- •Hypogonadism- serum testosterone less than 11 nmol/L on two samples
- •Peripheral Vascular Disease- ankle-brachial-pressure index <0.92 at baseline and symptoms.
- •Ability and agreement to comply with trial requirements after explanation in english language.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Current or previous breat or prostate malignancy.
- •Other active malignancy.
- •Raised prostate specific antigen level or abnormal rectal examination until cancer ruled out by specialist.
- •Treatment with testosterone in last three months.
- •Treatment with hormonallt active treatment apart from for diabetes in the last three months.
- •Involvement in another clinical trial in the last three months.
研究者
相似试验
进行中（未招募）
不适用
A randomised, double blind, placebo controlled study to Assess The Effect of Antibiotic Therapy on Chronic Rejection in Human Lung Transplantation - Azithromycin StudyPost Lung Transplantation Chronic Rejection identified as bronchiolitis obliterans syndrome (BOS)EUCTR2006-000485-36-GBewcastle upon Tyne Hospitals NHS Trust64
进行中（未招募）
不适用
A randomised, double-blind, placebo controlled study to assess the safety and the efficacy of neridronate 100 mg - 4 i.v. infusions in a course of 10 days treatment - in patients with algodystrophic syndrome. - NDEUCTR2007-003372-18-ITABIOGEN PHARMA
进行中（未招募）
不适用
A randomised, double-blind, placebo controlled study to evaluate the pharmacodynamics, safety, tolerability and pharmacokinetics profile of SLx-4090 over 14 days dosing in subjects with high triglyceride values.Dyslipidemia/hypertriglyceridemiaMedDRA version: 8.1Level: LLTClassification code 10058110Term: DyslipidemiaEUCTR2007-000536-95-DESurface Logix
进行中（未招募）
1 期
A randomised, double-blind, placebo controlled study of AIMSPRO in Multiple Sclerosis - AIMSPRO in MS bladder functioOveractive Bladder in Secondary Progressive Multiple Sclerosis and the other neurological symptoms associated with Secondary Progressive Multiple SclerosisMedDRA version: 9.1 Level: LLT Classification code 10063400 Term: Secondary progressive multiple sclerosisMedDRA version: 9.1 Level: LLT Classification code 10059617 Term: Overactive bladderMedDRA version: 9.1 Level: LLT Classification code 10012547 Term: Detrusor hyperreflexiaEUCTR2006-006872-39-GBDaval International Limited20
尚未招募
1 期
INNA-051 dry powder safety and tolerability studyRespiratory infectionInfection - Other infectious diseasesRespiratory - Other respiratory disorders / diseasesACTRN12624000635561ENA Respiratory Pty Ltd40